Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Acq. announced
Quarterly results
|
|
ONCOSEC MEDICAL Inc (ONCS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 06/02/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/26/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/25/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 5% stake in OncoSec Medical Incorporated |
| 05/19/2023 |
SC 13G
| SZOP Multistrat Management LLC reports a 5.6% stake in Oncosec Medical Incorporated |
| 05/18/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: __________, 2023 Initial Exercise Date: _____________, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on _______ [1] but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwi...",
"PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: May 18, 2023 Initial Exercise Date: May 18, 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on May 16, 2028 but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is being issued pursuant to t...",
"Letter re: Registration Statement on Form S-3",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 16, 2023, between OncoSec Medical Incorporated, a Nevada corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , as to the Shares, the Prefunded Warrants and Prefunded Warrant Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D promulgated thereunder as to the Common Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as mo...",
"Investor Contact",
"Investor Contact" |
|
| 05/18/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 04/17/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/03/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/27/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/28/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 02/22/2023 |
8-K
| Other Events Interactive Data |
| 02/14/2023 |
SC 13G/A
| Avidity Partners Management LP reports a 0% stake in Oncosec Medical Incorporated |
| 02/09/2023 |
4
| DelAversano Robert J (VP, Finance) has filed a Form 4 on ONCOSEC MEDICAL Inc|
Txns:
| Sold 40 shares
@ $1.37, valued at
$54.8 |
|
| 02/01/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 01/04/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 12/28/2022 |
8-K
| Quarterly results |
| 12/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/15/2022 |
10-Q
| Quarterly Report for the period ended October 31, 2022 |
| 12/12/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/02/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 12/01/2022 |
8-K
| Quarterly results |
| 12/01/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/01/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/29/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 11/29/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"ONCOSEC MEDICAL INCORPORATED Convertible Promissory Note and Security Agreement due November 25, 2024 Dated: November 25, 2022 $2,000,000.00 For value received, ONCOSEC MEDICAL INCORPORATED, a Nevada corporation , hereby promises to pay to the order of Grand Decade Developments Limited, a British Virgin Islands limited company and a wholly owned subsidiary of Grand Pharmaceutical Group Limited , in accordance with the terms hereinafter provided, the principal amount of $2 million together with interest thereon. All payments under or pursuant to this Note or the other Transaction Documents shall be made in United States Dollars in immediately available funds by wire transfer of funds to the Holder’ s account, instructions for which are set forth on Exhibit A . The outstanding principal bal..." |
|
| 11/28/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 11/23/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 11/22/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/15/2022 |
8-K
| Quarterly results |
|
|
|